Functional studies confirmed that regaining LAMB3 in miR-24-3p-overexpressing cells abrogated the anti-cancer effect induced by miR-24-3p and that LAMB3 inhibition abrogated the cancer-promoting effects induced by the miR-24-3p inhibitor. Here, LAMB3 is linked to cancer.